PBM Formulary Exclusions On The Rise, PhRMA Says
Access To Lower-Cost Insulin Affected
According to a report commissioned by PhRMA, the three largest pharmacy benefit managers continue to exclude more drugs from standard formularies, including those with expedited FDA approval.
